Biosimilars
Most recent (17)
Article
Woman looking at phone and medication

Express Scripts in 2023: Supporting clients, patients, and health plans

Over the last 12 months, Express Scripts has rolled out numerous groundbreaking programs and projects. Learn about some of the most notable advancements and innovations of 2023.

December 19, 23

Read More
Article
""

Preparing the market for the evolving biosimilar landscape

With more biosimilars and the first major influx of interchangeable inflammatory biosimilars coming to market, proactive education and outreach will be crucial for successful conversions to low-cost o...

Drew Mascolino, December 19, 23

Read More
Article
""

Research challenges PBM rebate narrative on rising insulin prices

Data shows that the greatest rates of price increase happened when rebates were at their lowest.

November 07, 23

Read More
Article
""

Pharmacy in Focus

See the future taking shape in pharmacy and how you can capitalize and prepare for 2024 and beyond.

October 09, 23

Read More
Article
""

Clinically Speaking: Boosting Biosimilars Competition and Savings

An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...

Christine Gilroy, MD, MSPH, September 25, 23

Read More
Article
""

Key considerations to support a robust biosimilar marketplace

We are taking a thoughtful and comprehensive approach to assessing biosimilar options that considers several factors.

July 24, 23

Read More